Published online January 2, 2007
PEDIATRICS Vol. 119 No. 1 January 2007, pp. e296-e300 (doi:10.1542/peds.2006-1009)
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hayani, A.
Right arrow Articles by Salvi, S. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hayani, A.
Right arrow Articles by Salvi, S. N.
Related Collections
Right arrow Blood

EXPERIENCE & REASON

First Report of Autologous Cord Blood Transplantation in the Treatment of a Child With Leukemia

Ammar Hayani, MDa, Eberhard Lampeter, MDb,c, David Viswanatha, MDd, David Morgan, MDe and Sharad N. Salvi, MDa

a Sections of Pediatric Hematology/Oncology
e Radiation Oncology, Advocate Hope Children's Hospital and Christ Medical Center, Oak Lawn, Illinois
b VITA34 International AG, Leipzig, Germany
c CorCell Inc, Philadelphia, Pennsylvania
d Department of Pathology, Mayo Clinic, Rochester, Minnesota

ABSTRACT

We present the case of a 3-year-old girl with acute lymphoblastic leukemia who developed isolated central nervous system relapse while receiving chemotherapy 10 months after diagnosis. The child achieved a second remission on retreatment with systemic and intrathecal chemotherapy. She then underwent myeloablative chemotherapy and radiation therapy followed by infusion of her own umbilical cord blood, which the parents had saved after her delivery. She is now doing well and is in complete remission 20 months after cord blood transplantation. In this first report of autologous cord blood transplantation for treatment of childhood leukemia, we discuss the safety and feasibility of this procedure as well as some of the uncertainties surrounding autologous cord blood collection and usage.

Key Words: umbilical cord blood • autologous • stem cell • transplantation • leukemia

Abbreviations: ALL, acute lymphoblastic leukemia • CNS, central nervous system • HSC, hematopoietic stem cell • UCB, umbilical cord blood • CR, complete remission • CBT, cord blood transplantation • IgH, immunoglobulin heavy chain • PCR, polymerase chain reaction • GVHD, graft-versus-host disease

Accepted Aug 10, 2006.




This article has been cited by other articles:


Home page
 BMJHome page
N. M Fisk and R. Atun
Public-private partnership in cord blood banking
BMJ, March 22, 2008; 336(7645): 642 - 644.
[Full Text] [PDF]

Home page
 Stem CellsHome page
M. Secco, E. Zucconi, N. M. Vieira, L. L.Q. Fogaca, A. Cerqueira, M. D. F. Carvalho, T. Jazedje, O. K. Okamoto, A. R. Muotri, and M. Zatz
Multipotent Stem Cells from Umbilical Cord: Cord Is Richer than Blood!
Stem Cells, January 1, 2008; 26(1): 146 - 150.
[Abstract] [Full Text] [PDF]